In the words of The Week's John Aziz:
"If the problem continues to grow, the U.S. and other countries will have to invest a whole lot more in antimicrobial technologies, or create incentives for Big Pharma to do so. Like the zombie apocalypse, the post-antibiotic world would not be a pretty place to live in."
It sure seems that next-gen antibiotics are not only a public health necessity, but also a good business--creating lifesaving products not only for Americans, but also to be sold to the world. It's also hard to see how we could "bend the curve" on healthcare costs if there's a big epidemic.